BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 15689382)

  • 1. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
    Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
    Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis.
    Chang CP; Neilson JR; Bayle JH; Gestwicki JE; Kuo A; Stankunas K; Graef IA; Crabtree GR
    Cell; 2004 Sep; 118(5):649-63. PubMed ID: 15339668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers of cardiac endocardial cushion development.
    Gitler AD; Lu MM; Jiang YQ; Epstein JA; Gruber PJ
    Dev Dyn; 2003 Dec; 228(4):643-50. PubMed ID: 14648841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis.
    Hiemisch H; Schütz G; Kaestner KH
    EMBO J; 1997 Jul; 16(13):3995-4006. PubMed ID: 9233809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.
    Lange AW; Molkentin JD; Yutzey KE
    Dev Biol; 2004 Feb; 266(2):346-60. PubMed ID: 14738882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-box binding sites are required for activity of a cardiac GATA-4 enhancer.
    Heicklen-Klein A; Evans T
    Dev Biol; 2004 Mar; 267(2):490-504. PubMed ID: 15013808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sculpting heart valves with NFATc and VEGF.
    Lambrechts D; Carmeliet P
    Cell; 2004 Sep; 118(5):532-4. PubMed ID: 15339657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hoxa5 gene regulation: A gradient of binding activity to a brachial spinal cord element.
    Nowling T; Zhou W; Krieger KE; Larochelle C; Nguyen-Huu MC; Jeannotte L; Tuggle CK
    Dev Biol; 1999 Apr; 208(1):134-46. PubMed ID: 10075847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development.
    Dodou E; Verzi MP; Anderson JP; Xu SM; Black BL
    Development; 2004 Aug; 131(16):3931-42. PubMed ID: 15253934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation.
    Wu B; Wang Y; Lui W; Langworthy M; Tompkins KL; Hatzopoulos AK; Baldwin HS; Zhou B
    Circ Res; 2011 Jul; 109(2):183-92. PubMed ID: 21597012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Pax2 in the intermediate mesoderm is regulated by YY1.
    Patel SR; Dressler GR
    Dev Biol; 2004 Mar; 267(2):505-16. PubMed ID: 15013809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis.
    Kuisk IR; Li H; Tran D; Capetanaki Y
    Dev Biol; 1996 Feb; 174(1):1-13. PubMed ID: 8626009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
    Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
    Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.
    Thompson JR; Huang DY; Gudas LJ
    Cell Growth Differ; 1998 Dec; 9(12):969-81. PubMed ID: 9869297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
    Iwahori A; Fraidenraich D; Basilico C
    Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis.
    Witte DP; Aronow BJ; Dry JK; Harmony JA
    Dev Dyn; 1994 Nov; 201(3):290-6. PubMed ID: 7881131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 activates the acetylcholinesterase promoter in rat muscle.
    Cohen TV; Randall WR
    J Neurochem; 2004 Sep; 90(5):1059-67. PubMed ID: 15312161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.